Anticancer Activity of Pristimerin in Epidermal Growth Factor Receptor 2-Positive SKBR3 Human Breast Cancer Cells
Jinsun Lee(University of California San Diego), Je Ryong Kim(Chungnam National University)
Cited by 54
Related Papers
Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation
|Molecular Medicine Reports|2018|47
Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway
|International Journal of Molecular Medicine|2019|39